Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Carbone

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 11, 2020
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)M Montopoli, S Zumerle, R Vettor, et al.
Oncogene|June 27, 2012
Aberrant expression of the neuronal-specific protein DCDC2 promotes malignant phenotypes and is associated with prostate cancer progressionN Longoni, P Kunderfranco, S Pellini, et al.
Oncogene|February 15, 2012
The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progressionF Babbio, C Pistore, L Curti, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 11, 2020
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)M Montopoli, S Zumerle, R Vettor, et al.
Oncogene|June 27, 2012
Aberrant expression of the neuronal-specific protein DCDC2 promotes malignant phenotypes and is associated with prostate cancer progressionN Longoni, P Kunderfranco, S Pellini, et al.
Oncogene|February 15, 2012
The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progressionF Babbio, C Pistore, L Curti, et al.
Pageof 2